FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210631611> ?p ?o ?g. }

• W4210631611 abstract "Lipid-lowering medications (LLM) are commonly used for secondary prevention, as well as for primary prevention among patients with high global cardiovascular risk and with diabetes. This study aimed to determine the prevalence of LLM use among high-risk individuals [participants with diabetes, high Framingham general cardiovascular (FRS-CVD) score, existing cardiovascular disease (CVD)] and the factors associated with it.This is a cross-sectional analysis from the baseline recruitment (years 2007 to 2011) of an ongoing prospective study involving 11,288 participants from 40 rural and urban communities in Malaysia. Multiple logistic regression was used to identify characteristics associated with LLM use.Majority (74.2%) of participants with CVD were not on LLM. Only 10.5% of participants with high FRS-CVD score, and 17.1% with diabetes were on LLM. Participants who were obese (OR = 1.80, 95% CI: 1.15-2.83), have diabetes (OR = 2.38, 95% CI: 1.78-3.19), have hypertension (OR = 2.87, 95% CI: 2.09-3.95), and attained tertiary education (OR = 2.25, 95% CI: 1.06-4.78) were more likely to be on LLM. Rural residents had lower odds of being on LLM (OR = 0.58, 95% CI: 0.41-0.82). In the primary prevention group, participants with high FRS-CVD score (OR = 3.81, 95% CI: 2.78-5.23) and high-income earners (OR = 1.54, 95% CI: 1.06-2.24) had higher odds of being on LLM.LLM use among high CVD-risk individuals in the primary prevention group, and also among individuals with existing CVD was low. While CVD risk factors and global cardiovascular risk score were positively associated with LLM use, sociodemographic disparities were observed among the less-educated, rural residents and low-income earners. Measures are needed to ensure optimal and equitable use of LLM." @default.
• W4210631611 created "2022-02-08" @default.
• W4210631611 creator A5017581149 @default.
• W4210631611 creator A5024601721 @default.
• W4210631611 creator A5038843699 @default.
• W4210631611 creator A5054255673 @default.
• W4210631611 creator A5059718264 @default.
• W4210631611 creator A5075037987 @default.
• W4210631611 date "2022-02-04" @default.
• W4210631611 modified "2023-10-04" @default.
• W4210631611 title "Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study" @default.
• W4210631611 cites W1509925720 @default.
• W4210631611 cites W1849680709 @default.
• W4210631611 cites W1984440698 @default.
• W4210631611 cites W2017602185 @default.
• W4210631611 cites W2098194481 @default.
• W4210631611 cites W2101781345 @default.
• W4210631611 cites W2116404316 @default.
• W4210631611 cites W2147663252 @default.
• W4210631611 cites W2148092884 @default.
• W4210631611 cites W2164089346 @default.
• W4210631611 cites W2253863748 @default.
• W4210631611 cites W2292665934 @default.
• W4210631611 cites W2419016626 @default.
• W4210631611 cites W2469278023 @default.
• W4210631611 cites W2514514030 @default.
• W4210631611 cites W2518984478 @default.
• W4210631611 cites W2592282778 @default.
• W4210631611 cites W2597938872 @default.
• W4210631611 cites W2766051043 @default.
• W4210631611 cites W2786243773 @default.
• W4210631611 cites W2804944249 @default.
• W4210631611 cites W2900034165 @default.
• W4210631611 cites W2908935992 @default.
• W4210631611 cites W2937027889 @default.
• W4210631611 cites W2941510061 @default.
• W4210631611 cites W2953804067 @default.
• W4210631611 cites W2999477413 @default.
• W4210631611 cites W3007371201 @default.
• W4210631611 cites W3017115099 @default.
• W4210631611 cites W3129818723 @default.
• W4210631611 cites W3129969560 @default.
• W4210631611 cites W3138571020 @default.
• W4210631611 cites W3157595528 @default.
• W4210631611 cites W3173884780 @default.
• W4210631611 cites W3183857127 @default.
• W4210631611 cites W3191512536 @default.
• W4210631611 doi "https://doi.org/10.1186/s12889-022-12595-1" @default.
• W4210631611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35120488" @default.
• W4210631611 hasPublicationYear "2022" @default.
• W4210631611 type Work @default.
• W4210631611 citedByCount "6" @default.
• W4210631611 countsByYear W42106316112022 @default.
• W4210631611 countsByYear W42106316112023 @default.
• W4210631611 crossrefType "journal-article" @default.
• W4210631611 hasAuthorship W4210631611A5017581149 @default.
• W4210631611 hasAuthorship W4210631611A5024601721 @default.
• W4210631611 hasAuthorship W4210631611A5038843699 @default.
• W4210631611 hasAuthorship W4210631611A5054255673 @default.
• W4210631611 hasAuthorship W4210631611A5059718264 @default.
• W4210631611 hasAuthorship W4210631611A5075037987 @default.
• W4210631611 hasBestOaLocation W42106316111 @default.
• W4210631611 hasConcept C107130276 @default.
• W4210631611 hasConcept C11783203 @default.
• W4210631611 hasConcept C126322002 @default.
• W4210631611 hasConcept C134018914 @default.
• W4210631611 hasConcept C140556311 @default.
• W4210631611 hasConcept C151956035 @default.
• W4210631611 hasConcept C156957248 @default.
• W4210631611 hasConcept C2779134260 @default.
• W4210631611 hasConcept C555293320 @default.
• W4210631611 hasConcept C71924100 @default.
• W4210631611 hasConcept C74909509 @default.
• W4210631611 hasConcept C99454951 @default.
• W4210631611 hasConceptScore W4210631611C107130276 @default.
• W4210631611 hasConceptScore W4210631611C11783203 @default.
• W4210631611 hasConceptScore W4210631611C126322002 @default.
• W4210631611 hasConceptScore W4210631611C134018914 @default.
• W4210631611 hasConceptScore W4210631611C140556311 @default.
• W4210631611 hasConceptScore W4210631611C151956035 @default.
• W4210631611 hasConceptScore W4210631611C156957248 @default.
• W4210631611 hasConceptScore W4210631611C2779134260 @default.
• W4210631611 hasConceptScore W4210631611C555293320 @default.
• W4210631611 hasConceptScore W4210631611C71924100 @default.
• W4210631611 hasConceptScore W4210631611C74909509 @default.
• W4210631611 hasConceptScore W4210631611C99454951 @default.
• W4210631611 hasIssue "1" @default.
• W4210631611 hasLocation W42106316111 @default.
• W4210631611 hasLocation W42106316112 @default.
• W4210631611 hasLocation W42106316113 @default.
• W4210631611 hasOpenAccess W4210631611 @default.
• W4210631611 hasPrimaryLocation W42106316111 @default.
• W4210631611 hasRelatedWork W1563850031 @default.
• W4210631611 hasRelatedWork W2006248328 @default.
• W4210631611 hasRelatedWork W2060454288 @default.
• W4210631611 hasRelatedWork W2161655249 @default.
• W4210631611 hasRelatedWork W2246581496 @default.
• W4210631611 hasRelatedWork W2320601639 @default.
• W4210631611 hasRelatedWork W2337346542 @default.
• W4210631611 hasRelatedWork W2415759662 @default.

• next